Cargando…

846. Trends in Acinetobacter baumanii Antibiotic Resistance Rates

BACKGROUND: Carbapenem-resistant Acinetobacter baumannii is described as an urgent threat by the Centers for Disease Control and Prevention and several older studies have indicated increasing resistance in Acinetobacter. We sought to describe these trends in the national Veterans Affairs (VA) Health...

Descripción completa

Detalles Bibliográficos
Autores principales:	Caffrey, Aisling, O’Neill, Emily T, Appaneal, Haley J, Lopes, Vrishali, LaPlante, Kerry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776211/ http://dx.doi.org/10.1093/ofid/ofaa439.1035

Ejemplares similares

1610. Epidemiology and Treatment Heterogeneity in Acinetobacter baumanii Infections
por: Caffrey, Aisling, et al.
Publicado: (2020)

847. Trends in Stenotrophomonas maltophilia Antibiotic Resistance Rates
por: Caffrey, Aisling, et al.
Publicado: (2020)

2049. Trends in Antibiotic Use and Antibiotic Resistance among Veterans Affairs Community Living Centers from 2011 to 2017
por: Appaneal, Haley, et al.
Publicado: (2019)

Antibiotic Prescribing in Outpatient Settings: Rural Patients Are More Likely to Receive Fluoroquinolones and Longer Antibiotic Courses
por: Appaneal, Haley J., et al.
Publicado: (2023)

1585. Stenotrophomonas maltophilia Infections and Approaches to Treatment
por: Caffrey, Aisling, et al.
Publicado: (2020)

Decreasing Antibiotic Resistance Trends Nationally in Gram-Negative Bacteria Across United States Veterans Affairs Medical Centers, 2011–2020
por: Liao, J. Xin, et al.
Publicado: (2023)

470. Concomitant Antibiotic Use and Death Among a National Cohort of Veterans With Clostridium difficile Infection (CDI)
por: Appaneal, Haley, et al.
Publicado: (2018)

2012. Trends in Microbiological Culture Collection Across Veterans Affairs Medical Centers and Community Living Centers, 2010 to 2017
por: Appaneal, Haley, et al.
Publicado: (2019)

Assessing Rates of Co-Resistance and Patient Outcomes in Multidrug-Resistant Pseudomonas aeruginosa
por: Appaneal, Haley J., et al.
Publicado: (2022)

1238. A National Comparison of Antibiograms Between Veterans Affairs Long-Term Care Facilities and Affiliated Hospitals
por: Tolg, Maria-Stephanie, et al.
Publicado: (2018)

Post-Discharge Antibiotic Therapy in Patients with Acute Bacterial Skin and Skin Structure Infections
por: Caffrey, Aisling, et al.
Publicado: (2017)

Poor clinical outcomes associated with suboptimal antibiotic treatment among older long-term care facility residents with urinary tract infection: a retrospective cohort study
por: Appaneal, Haley J., et al.
Publicado: (2021)

264. Anti-platelet Therapy Significantly Reduces Inpatient Mortality in Patients with Staphylococcus aureus Bacteremia
por: Caffrey, Aisling, et al.
Publicado: (2020)

The Comparative Effectiveness of Ceftolozane/Tazobactam versus Aminoglycoside- or Polymyxin-Based Regimens in Multi-Drug-Resistant Pseudomonas aeruginosa Infections
por: Caffrey, Aisling R., et al.
Publicado: (2022)

Heterogeneity in the treatment of bloodstream infections identified from antibiotic exposure mapping
por: Caffrey, Aisling R., et al.
Publicado: (2019)

Impact of Vancomycin-Associated Acute Kidney Injury on Patient Outcomes in MRSA Bacteremia
por: Luther, Megan, et al.
Publicado: (2017)

1067. Comparative Effectiveness of Nafcillin or Oxacillin, Cefazolin, and Piperacillin/Tazobactam in Methicillin-Sensitive Staphylococcus aureus Bacteremia
por: Beganovic, Maya, et al.
Publicado: (2018)

1628. Treatment Heterogeneity in Pseudomonas aeruginosa Pneumonia
por: Caffrey, Aisling, et al.
Publicado: (2020)

699. Relationship Between Klebsiella pneumoniae Antimicrobial Resistance and Biofilm Formation
por: Cusumano, Jaclyn, et al.
Publicado: (2018)

2291. Evaluation of Multidrug-Resistant Pseudomonas aeruginosa Isolates in Patients Receiving Ceftolozane/tazobactam
por: Bodo, Emily C, et al.
Publicado: (2019)

The antibiotic resistance proteome of Acinetobacter baumanii MDR isolate MMC#4
por: Marshall, Dana, et al.
Publicado: (2012)

Predictors of 30-day All-cause Mortality in Veterans with First Recurrence of Clostridium difficile Infection (CDI)
por: Morrill, Haley, et al.
Publicado: (2017)

Treatment Heterogeneity in Pseudomonas aeruginosa Pneumonia
por: Caffrey, Aisling R., et al.
Publicado: (2022)

Erratum to: Epidemiology of Pneumococcal Disease in a National Cohort of Older Adults
por: Morrill, Haley J., et al.
Publicado: (2014)

Epidemiology of Pneumococcal Disease in a National Cohort of Older Adults
por: Morrill, Haley J., et al.
Publicado: (2014)

557. Trends in Remdesivir Treatment Over the Course of the COVID-19 Pandemic
por: Xin Liao, J, et al.
Publicado: (2021)

Successful treatment of multicompartmental cerebral ventriculitis caused by Acinetobacter baumanii
por: Mahoney, Dom, et al.
Publicado: (2017)

S33.1 Multidrug-resistant Acinetobacter baumanii and Pseudomonas aeruginosa
Publicado: (2005)

Impact of a Prospective Audit and Feedback Antimicrobial Stewardship Program at a Veterans Affairs Medical Center: A Six-Point Assessment
por: Morrill, Haley J., et al.
Publicado: (2016)

An outbreak of Acinetobacter baumanii in an ICU: effectiveness of an extensive infection control program
por: Bonizzoli, M, et al.
Publicado: (2006)

Use of daptomycin and vancomycin in blood stream infections with PDR Acinetobacter Baumanii
por: Alexandropoulos, P, et al.
Publicado: (2015)

Minocycline: The second important antimicrobial in multidrug-resistant Acinetobacter baumanii infections
por: Nair, Abhijit S.
Publicado: (2018)

Assessments of Opportunities to Improve Antibiotic Prescribing in an Emergency Department: A Period Prevalence Survey
por: Timbrook, Tristan T., et al.
Publicado: (2017)

1630. What is Treatment Time Zero Among Hospitalized Patients with Bacteremia?
por: Caffrey, Aisling, et al.
Publicado: (2020)

Clinical experiment with the use of colistin for the treatment of multiresistant Acinetobacter baumanii nosocomial infection
por: Safi, L, et al.
Publicado: (2009)

Control and Elimination of Extensively Drug-Resistant Acinetobacter baumanii in an Intensive Care Unit
por: Chamieh, Amanda, et al.
Publicado: (2019)

Improved survival with continuation of statins in bacteremic patients
por: Pawar, Ajinkya M, et al.
Publicado: (2018)

Inappropriate prescribing in outpatient healthcare: an evaluation of respiratory infection visits among veterans in teaching versus non-teaching primary care clinics
por: Parente, Diane M., et al.
Publicado: (2017)

Intrathecal (intraventricular) polymyxin B in the treatment of patients with meningoencephalitis by Acinetobacter baumanii and Pseudomonas aeruginosa
por: Macedo, SK, et al.
Publicado: (2011)

Management of an outbreak of multiresistant Acinetobacter baumanii infection in a surgical intensive care unit
por: Lewejohann, J, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_kn8f3cmccgoi1gj0h2toea18rg